Company Analysis

Aclarion, Inc. (ACON)

Nasdaq: ACON · Services-Medical Laboratories · Broomfield, CO · filing with the SEC since 2015
Grade3.5
◀ Past 1.2● Present 2.8▶ Future 6.8
2 est.

Filings

221 filings since 2017 beside 54 insider forms · Non-accelerated filer and smaller reporting company and emerging growth company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company and emerging growth company
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by May 15, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Apr 27, 2026.

Filings a yearinsider forms included
1135656784534
20182020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 2 times in the last 36 months, the newest Sep 3, 2025.Listing warning from its exchange (8-K item 3.01): 3 times in the last 36 months, the newest Oct 11, 2024.SEC letters: 20 in the last 36 months, the newest Apr 30, 2025.A late-filing notice, Form NT 10-K, filed Mar 31, 2025.
Insider forms 54

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 5, 2026 10-Q Quarterly report Sep 30, 2026
Aug 6, 2026 10-Q Quarterly report Jun 30, 2026
Jul 9, 2026 S-8 Employee stock plan registration
Jun 4, 2026 8-K item 5.07 Shareholder vote · Current report
May 13, 2026 10-Q Quarterly report Mar 31, 2026
Apr 27, 2026 DEF 14A Proxy statement Jun 4, 2026
Apr 22, 2026 8-K items 8.01, 9.01 Other event · Current report Apr 21, 2026
Apr 3, 2026 PRE 14A Preliminary proxy statement Jun 4, 2026
Mar 25, 2026 SCHEDULE 13G Large holder notice
Mar 19, 2026 8-K items 1.01, 3.03, 5.03, 8.01, 9.01 Major agreement signed; Change to shareholders' rights; Charter, bylaw or fiscal-year change; Other event · Current report
Mar 19, 2026 8-A12B Class of securities registered for listing
Mar 18, 2026 10-K Annual report Dec 31, 2025
Jan 13, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report Jan 9, 2026
Jan 9, 2026 8-K items 1.01, 9.01 Major agreement signed · Current report Jan 8, 2026
Jan 9, 2026 424B5 Shelf offering
Nov 12, 2025 10-Q Quarterly report Sep 30, 2025
Oct 14, 2025 8-K items 1.01, 9.01 Major agreement signed · Current report Oct 13, 2025
Oct 14, 2025 424B5 Shelf offering
Sep 3, 2025 8-K items 1.01, 5.02, 7.01, 9.01 Major agreement signed; Officer or director change; Investor disclosure (Regulation FD) · Current report Sep 2, 2025
Aug 14, 2025 10-Q Quarterly report Jun 30, 2025
Jul 21, 2025 8-K item 5.07 Shareholder vote · Current report
Jul 7, 2025 DEFA14A Extra proxy material
Jul 7, 2025 8-K items 5.07, 7.01, 9.01 Shareholder vote; Investor disclosure (Regulation FD) · Current report
Jun 20, 2025 8-K item 5.02 Officer or director change · Current report Jun 16, 2025
May 15, 2025 10-Q Quarterly report Mar 31, 2025
May 13, 2025 DEF 14A Proxy statement Jul 7, 2025
May 5, 2025 EFFECT Registration effective
May 2, 2025 PRE 14A Preliminary proxy statement Jul 31, 2025
Apr 30, 2025 CORRESP Reply to the SEC
Apr 29, 2025 UPLOAD SEC comment letter
Apr 25, 2025 S-3 Shelf registration
Apr 23, 2025 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Apr 9, 2025 10-K Annual report Dec 31, 2024
Mar 31, 2025 NT 10-K Late annual report notice Dec 31, 2024
Mar 28, 2025 8-K items 3.03, 5.03, 9.01 Change to shareholders' rights; Charter, bylaw or fiscal-year change · Current report Mar 27, 2025
Mar 13, 2025 8-K item 8.01 Other event · Current report
Mar 6, 2025 8-K item 5.07 Shareholder vote · Current report Mar 5, 2025
Feb 28, 2025 8-K items 5.07, 7.01, 9.01 Shareholder vote; Investor disclosure (Regulation FD) · Current report
Feb 28, 2025 DEFA14A Extra proxy material
Feb 13, 2025 SCHEDULE 13G/A Large holder update, amended
40 of 221 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton ACON · research, not advice